Syros Pharmaceuticals, Inc. - common stock (SYRS): Price and Financial Metrics
SYRS Price/Volume Stats
| Current price | $0.08 | 52-week high | $6.93 |
| Prev. close | $0.12 | 52-week low | $0.07 |
| Day low | $0.07 | Volume | 2,757,512 |
| Day high | $0.10 | Avg. volume | 26,428,729 |
| 50-day MA | $0.16 | Dividend yield | N/A |
| 200-day MA | $2.10 | Market Cap | 2.15M |
SYRS Stock Price Chart Interactive Chart >
Syros Pharmaceuticals, Inc. - common stock (SYRS) Company Bio
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing medicines that control genes to transform the lives of patients with cancer, immune-mediated diseases, and other diseases. The company was founded in 2011 and is based in Cambridge, Massachusetts.
SYRS Price Returns
| 1-mo | -59.23% |
| 3-mo | -60.00% |
| 6-mo | -95.90% |
| 1-year | -98.74% |
| 3-year | -99.27% |
| 5-year | -99.86% |
| YTD | -65.19% |
| 2024 | -97.05% |
| 2023 | 116.99% |
| 2022 | -88.99% |
| 2021 | -69.95% |
| 2020 | 57.02% |
Continue Researching SYRS
Want to see what other sources are saying about Syros Pharmaceuticals Inc's financials and stock price? Try the links below:Syros Pharmaceuticals Inc (SYRS) Stock Price | Nasdaq
Syros Pharmaceuticals Inc (SYRS) Stock Quote, History and News - Yahoo Finance
Syros Pharmaceuticals Inc (SYRS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...